Cost of revenue increased 35.6%
Cost of revenue changed +35.6% from the comparable as-filed period.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Cost of revenue changed +35.6% from the comparable as-filed period.
Stock-based compensation changed +49.5% from the comparable as-filed period.
Current liabilities changed +21.4% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Operating cash-flow margin changed -2879 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Gross margin changed -75 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Total assets changed +17.2% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes. This reverses 2 consecutive comparable moves in the opposite direction.
Shares outstanding changed +18.9% from the comparable as-filed period. The change ranks at the 43th percentile of 7 prior comparable changes.
Capital expenditure changed -84.0% from the comparable as-filed period.
Free-cash-flow margin changed -2849 basis points from the comparable as-filed period.
SBC / revenue changed +115 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Trade receivables changed +11.8% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes. This reverses 2 consecutive comparable moves in the opposite direction.
Selling, general & administrative changed +7.4% from the comparable as-filed period.
Current ratio changed +10.2% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes. This reverses 2 consecutive comparable moves in the opposite direction.
Receivables / revenue changed -140 basis points from the comparable as-filed period.
Capex / revenue changed -30 basis points from the comparable as-filed period.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.